Back
BeiGene Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
45
BGNE
BeiGene
Last Price:
174.42
Seasonality Move:
13.38%
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
65.29
Seasonality Move:
-6.93%
Sell
45
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $174.32. The Score for BGNE is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BGNE Stock Price Chart
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $65.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.
BGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.54 | Buy |
| Relative Strength Index (14 RSI): | 67.82 | Buy |
| Chaikin Money Flow: | 38809 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.5 - 168.16) | Buy |
| Bollinger Bands (100): | (146.24 - 171) | Buy |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.32 | Sell |
| Relative Strength Index (14 RSI): | 41.48 | Sell |
| Chaikin Money Flow: | 421582 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.45 - 74.29) | Sell |
| Bollinger Bands (100): | (65.99 - 72.19) | Sell |
BGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 166.97 | Buy |
| 20-day SMA: | 160 | Buy |
| 50-day SMA: | 155.71 | Buy |
| 200-day SMA: | 173.23 | Buy |
| 8-day EMA: | 167.84 | Buy |
| 20-day EMA: | 161.41 | Buy |
| 50-day EMA: | 157.78 | Buy |
| 200-day EMA: | 171.99 | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.78 | Sell |
| 20-day SMA: | 69.19 | Sell |
| 50-day SMA: | 68.67 | Sell |
| 200-day SMA: | 62.8 | Buy |
| 8-day EMA: | 66.34 | Sell |
| 20-day EMA: | 68 | Sell |
| 50-day EMA: | 68.71 | Sell |
| 200-day EMA: | 64.66 | Buy |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.93 per share, an increase next quarter of $0.95 per share, a decrease this year of $0.33 per share, and an increase next year of $5.07 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.
BeiGene Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||